Bridgewater Wealth & Financial Management LLC Acquires New Stake in Becton, Dickinson and Company (BDX)

Bridgewater Wealth & Financial Management LLC acquired a new position in Becton, Dickinson and Company (NYSE:BDX) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,176 shares of the medical instruments supplier’s stock, valued at approximately $229,000.

Other institutional investors have also added to or reduced their stakes in the company. Almanack Investment Partners LLC. bought a new position in Becton, Dickinson and during the 1st quarter valued at $105,000. Parkside Financial Bank & Trust raised its holdings in shares of Becton, Dickinson and by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock worth $116,000 after purchasing an additional 9 shares during the period. QCI Asset Management Inc. NY raised its holdings in shares of Becton, Dickinson and by 9.2% during the first quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock worth $130,000 after purchasing an additional 60 shares during the period. Financial Architects Inc raised its holdings in shares of Becton, Dickinson and by 8.0% during the second quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock worth $142,000 after purchasing an additional 54 shares during the period. Finally, Guardian Life Insurance Co. of America raised its holdings in shares of Becton, Dickinson and by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 819 shares of the medical instruments supplier’s stock worth $150,000 after purchasing an additional 6 shares during the period. 87.12% of the stock is owned by institutional investors.

A number of analysts have weighed in on the stock. Stifel Nicolaus reissued a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday, August 9th. Cowen and Company reaffirmed a “buy” rating and issued a $230.00 price objective on shares of Becton, Dickinson and in a report on Monday, August 14th. Barclays PLC reaffirmed an “equal weight” rating and issued a $210.00 price objective (up previously from $205.00) on shares of Becton, Dickinson and in a report on Thursday, August 10th. BidaskClub raised shares of Becton, Dickinson and from a “hold” rating to a “buy” rating in a report on Monday, August 14th. Finally, Zacks Investment Research cut shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Monday, August 7th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. Becton, Dickinson and presently has a consensus rating of “Buy” and a consensus price target of $196.93.

In related news, EVP Ribo Alberto Mas sold 7,463 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $201.41, for a total value of $1,503,122.83. Following the completion of the transaction, the executive vice president now directly owns 29,323 shares in the company, valued at approximately $5,905,945.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Ellen R. Strahlman sold 9,283 shares of the business’s stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $198.21, for a total value of $1,839,983.43. Following the completion of the transaction, the insider now owns 26,638 shares of the company’s stock, valued at $5,279,917.98. The disclosure for this sale can be found here. Insiders sold a total of 75,904 shares of company stock valued at $15,242,688 over the last quarter. 1.40% of the stock is owned by insiders.

Shares of Becton, Dickinson and Company (BDX) opened at 195.34 on Monday. The firm has a market capitalization of $44.45 billion, a PE ratio of 56.57 and a beta of 1.06. The company’s 50 day moving average is $199.43 and its 200 day moving average is $191.33. Becton, Dickinson and Company has a 12-month low of $161.29 and a 12-month high of $206.63.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The business had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.06 billion. During the same period in the previous year, the firm earned $2.35 EPS. Becton, Dickinson and’s quarterly revenue was down 5.1% compared to the same quarter last year. On average, analysts forecast that Becton, Dickinson and Company will post $9.46 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 8th will be given a $0.73 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.92 annualized dividend and a dividend yield of 1.49%. Becton, Dickinson and’s dividend payout ratio is presently 83.43%.

COPYRIGHT VIOLATION NOTICE: “Bridgewater Wealth & Financial Management LLC Acquires New Stake in Becton, Dickinson and Company (BDX)” was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/09/18/bridgewater-wealth-financial-management-llc-acquires-new-stake-in-becton-dickinson-and-company-bdx.html.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply